| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | David J Thomas | |
| Ilona Jaspers | |||
| Miroslav Stýblo | |||
| Zuzana Drobná | |||
| Shan Lin | |||
| P2860 | cites work | Arsenic induces oxidant stress and NF-KB activation in cultured aortic endothelial cells | Q23909531 |
| Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation | Q23923186 | ||
| Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily | Q24291575 | ||
| The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase | Q24561826 | ||
| Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine | Q24811006 | ||
| Dermatotoxic chemical stimulate of c-jun and c-fos transcription and AP-1 DNA binding in human keratinocytes | Q26344234 | ||
| Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms? | Q26345064 | ||
| Thioredoxin and glutaredoxin systems | Q28271236 | ||
| Enzymatic reduction of arsenic compounds in mammalian systems: the rate-limiting enzyme of rabbit liver arsenic biotransformation is MMA(V) reductase | Q28377855 | ||
| A novel S-adenosyl-L-methionine:arsenic(III) methyltransferase from rat liver cytosol | Q28584169 | ||
| Enzymatic reduction of arsenic compounds in mammalian systems: reduction of arsenate to arsenite by human liver arsenate reductase | Q33887956 | ||
| Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes | Q33891890 | ||
| Speciation of key arsenic metabolic intermediates in human urine. | Q33925487 | ||
| Methylated trivalent arsenic species are genotoxic | Q33942554 | ||
| Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites | Q33943279 | ||
| Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. | Q33951760 | ||
| Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver | Q34062420 | ||
| Thioredoxin structure and mechanism: conformational changes on oxidation of the active-site sulfhydryls to a disulfide | Q34313529 | ||
| The cellular metabolism and systemic toxicity of arsenic | Q34401625 | ||
| Drinking water and cancer | Q34834122 | ||
| Arsenic ingestion and internal cancers: a review | Q36039612 | ||
| Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic | Q40751318 | ||
| Determination of trivalent methylated arsenicals in biological matrices. | Q40788453 | ||
| Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes | Q40811439 | ||
| Induction of p53 protein expression by sodium arsenite | Q41071070 | ||
| Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. | Q43576159 | ||
| Reactions of arsenic(III) and arsenic(V) species with glutathione | Q46619791 | ||
| Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man. | Q49226505 | ||
| Arsenic in drinking water and incidence of urinary cancers. | Q50938966 | ||
| Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells | Q56114256 | ||
| Mono- and dimethylation of arsenic in rat liver cytosol in vitro | Q71056467 | ||
| Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance study | Q72360120 | ||
| Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase | Q73091945 | ||
| Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols | Q73165117 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | arsenic | Q871 |
| inorganic compound | Q190065 | ||
| toxicity | Q274160 | ||
| dysplasia | Q1128996 | ||
| P304 | page(s) | 767-771 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | Environmental Health Perspectives | Q1345904 |
| P1476 | title | The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update | |
| P478 | volume | 110 Suppl 5 |
| Q42703088 | Alleviative effect of quercetin on rat testis against arsenic: a histological and biochemical study |
| Q34478447 | An Emerging Role for Epigenetic Dysregulation in Arsenic Toxicity and Carcinogenesis |
| Q47874435 | An investigation of the health effects caused by exposure to arsenic from drinking water and coal combustion: arsenic exposure and metabolism |
| Q42871604 | Arsenic (+3 oxidation state) methyltransferase genotype affects steady-state distribution and clearance of arsenic in arsenate-treated mice |
| Q44038074 | Arsenic Metabolites and Methylation Capacity Among Individuals Living in a Rural Area with Endemic Arseniasis in Inner Mongolia, China |
| Q28387404 | Arsenic and cardiovascular disease |
| Q26823611 | Arsenic and human health: epidemiologic progress and public health implications |
| Q28389752 | Arsenic binding to proteins |
| Q34478909 | Arsenic detoxification and evolution of trimethylarsine gas by a microbial arsenite S-adenosylmethionine methyltransferase |
| Q23917625 | Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Sonora, Mexico |
| Q28394700 | Arsenic exposure and the induction of human cancers |
| Q28386482 | Arsenic exposure from drinking water, arsenic methylation capacity, and carotid intima-media thickness in Bangladesh |
| Q34063005 | Arsenic metabolism by human gut microbiota upon in vitro digestion of contaminated soils |
| Q28388822 | Arsenic methylation and lung and bladder cancer in a case-control study in northern Chile |
| Q44967698 | Arsenic methylation capacity and its correlation with skin lesions induced by contaminated drinking water consumption in residents of chronic arsenicosis area |
| Q51250750 | Arsenic methylation metabolism and liver injury of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. |
| Q39620554 | Arsenic speciation in human hair: a new perspective for epidemiological assessment in chronic arsenicism. |
| Q30339021 | Arsenic toxicity, mutagenesis, and carcinogenesis--a health risk assessment and management approach. |
| Q28392539 | Arsenic, asbestos and radon: emerging players in lung tumorigenesis |
| Q42701592 | Arsenic-induced dyslipidemia in male albino rats: comparison between trivalent and pentavalent inorganic arsenic in drinking water |
| Q33695479 | Arsenite suppression of involucrin transcription through AP1 promoter sites in cultured human keratinocytes |
| Q36042152 | As(III) S-adenosylmethionine methyltransferases and other arsenic binding proteins |
| Q104250315 | Assessment of Methods for Determining Bioavailability of Trace Elements in Soils: A Review |
| Q34033971 | Association of genetic variation in cystathionine-β-synthase and arsenic metabolism |
| Q40149535 | Associations between arsenic (+3 oxidation state) methyltransferase (AS3MT) and N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms, arsenic metabolism, and cancer risk in a chilean population |
| Q39833724 | BRCA2-dependent homologous recombination is required for repair of Arsenite-induced replication lesions in mammalian cells |
| Q37635891 | Baseline comorbidities in a skin cancer prevention trial in Bangladesh |
| Q28660994 | Basic mechanics of DNA methylation and the unique landscape of the DNA methylome in metal-induced carcinogenesis |
| Q36456159 | Chronic Exposure to Arsenic and Markers of Cardiometabolic Risk: A Cross-Sectional Study in Chihuahua, Mexico |
| Q28387209 | Chronic arsenic exposure increases TGFalpha concentration in bladder urothelial cells of Mexican populations environmentally exposed to inorganic arsenic |
| Q35902001 | Conditioned flavor aversion and brain Fos expression following exposure to arsenic |
| Q34599799 | Creatinine, arsenic metabolism, and renal function in an arsenic-exposed population in Bangladesh |
| Q34109590 | Crystallization and preliminary X-ray crystallographic analysis of the ArsM arsenic(III) S-adenosylmethionine methyltransferase. |
| Q60952691 | Cutaneous Malignancy due to Arsenicosis in Bangladesh: 12-Year Study in Tertiary Level Hospital |
| Q48461633 | Decreased nitric oxide production in the rat brain after chronic arsenic exposure. |
| Q24676002 | Developmental and genetic modulation of arsenic biotransformation: a gene by environment interaction? |
| Q24536026 | Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children |
| Q23911286 | Dietary intake and arsenic methylation in a U.S. population |
| Q28385521 | Differences in urinary arsenic metabolites between diabetic and non-diabetic subjects in Bangladesh |
| Q33963931 | Differences of urinary arsenic metabolites and methylation capacity between individuals with and without skin lesions in Inner Mongolia, Northern China |
| Q37721696 | Differential binding of monomethylarsonous acid compared to arsenite and arsenic trioxide with zinc finger peptides and proteins |
| Q28397251 | Differential methylation of the arsenic (III) methyltransferase promoter according to arsenic exposure |
| Q25256850 | Distinct gene expression profiles in immortalized human urothelial cells exposed to inorganic arsenite and its methylated trivalent metabolites |
| Q48523876 | Distribution and speciation of arsenic by transplacental and early life exposure to inorganic arsenic in offspring rats |
| Q46333128 | Effects of Inorganic Arsenic, Methylated Arsenicals, and Arsenobetaine on Atherosclerosis in the Mouse Model and the Role of As3mt-Mediated Methylation |
| Q35573874 | Elevation of cellular BPDE uptake by human cells: a possible factor contributing to co-carcinogenicity by arsenite |
| Q38605998 | Environmental factors in cardiovascular disease |
| Q34897566 | Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation |
| Q36838009 | Epigenetic remodeling during arsenical-induced malignant transformation. |
| Q21245830 | Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapán and Lagunera regions in Mexico |
| Q38960886 | Expression Of Selected Pathway-Marker Genes In Human Urothelial Cells Exposed Chronically To A Non-Cytotoxic Concentration Of Monomethylarsonous Acid. |
| Q36441613 | Expression of AS3MT alters transcriptional profiles in human urothelial cells exposed to arsenite |
| Q28066453 | Factors Affecting Arsenic Methylation in Arsenic-Exposed Humans: A Systematic Review and Meta-Analysis |
| Q28397017 | Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh |
| Q37201232 | Folate, Cobalamin, Cysteine, Homocysteine, and Arsenic Metabolism among Children in Bangladesh |
| Q24811655 | Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh |
| Q91992770 | Functional Profiling Identifies Determinants of Arsenic Trioxide Cellular Toxicity |
| Q35426674 | Genetic polymorphisms in glutathione S-transferase (GST) superfamily and risk of arsenic-induced urothelial carcinoma in residents of southwestern Taiwan. |
| Q46328237 | Genotoxicity induced by monomethylarsonous acid (MMA+3) in mouse thymic developing T cells |
| Q35633033 | Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid |
| Q57541950 | Health Effects Associated with Inhalation of Airborne Arsenic Arising from Mining Operations |
| Q36089643 | High-throughput screening-compatible assays of As(III) S-adenosylmethionine methyltransferase activity |
| Q35844220 | Identification of Small Molecule Inhibitors of Human As(III) S-Adenosylmethionine Methyltransferase (AS3MT) |
| Q36088753 | Identification of an S-adenosylmethionine (SAM) dependent arsenic methyltransferase in Danio rerio |
| Q41869380 | Identification of catalytic residues in the As(III) S-adenosylmethionine methyltransferase. |
| Q46552512 | In Vivo and In Vitro Arsenic Exposition Induces Oxidative Stress in Anterior Pituitary Gland |
| Q28396987 | Increased hexokinase II expression in the renal glomerulus of mice in response to arsenic |
| Q36611446 | Indigenous American ancestry is associated with arsenic methylation efficiency in an admixed population of northwest Mexico. |
| Q28392195 | Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina |
| Q35607441 | Induction of human squamous cell-type carcinomas by arsenic |
| Q28395582 | Influence of GSTT1 Genetic Polymorphisms on Arsenic Metabolism |
| Q33569457 | Influence of cobalamin on arsenic metabolism in Bangladesh |
| Q28383469 | Inorganic arsenic and human prostate cancer |
| Q39251501 | Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells |
| Q39184989 | Knockout of arsenic (+3 oxidation state) methyltransferase is associated with adverse metabolic phenotype in mice: the role of sex and arsenic exposure |
| Q34582726 | Levels and chemical speciation of arsenic in representative biota and sediments of a tropical mangrove wetland, India. |
| Q82741833 | Metabolic profile and assessment of occupational arsenic exposure in copper- and steel-smelting workers in China |
| Q36628920 | Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. |
| Q37658372 | Metabolism of arsenic in human liver: the role of membrane transporters |
| Q40582666 | Metal toxicity at the synapse: presynaptic, postsynaptic, and long-term effects |
| Q58390492 | Methylated Organic Metabolites of Arsenic and their Cardiovascular Toxicities |
| Q34567906 | Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment |
| Q36895189 | Methylated trivalent arsenicals are potent inhibitors of glucose stimulated insulin secretion by murine pancreatic islets |
| Q28396910 | Molecular features in arsenic-induced lung tumors |
| Q33917979 | Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure |
| Q42477840 | NFE2L2 Gene Variants and Arsenic Susceptibility: A Lymphoblastoid Model. |
| Q64066521 | Natural variation in arsenic toxicity is explained by differences in branched chain amino acid metabolism |
| Q48108039 | Nonsynonymous Polymorphisms in the Human AS3MT Arsenic Methylation Gene: Implications for Arsenic Toxicity |
| Q28383595 | Nutritional status has marginal influence on the metabolism of inorganic arsenic in pregnant Bangladeshi women |
| Q43213354 | Oncogene expression profiles in K6/ODC mouse skin and papillomas following a chronic exposure to monomethylarsonous acid |
| Q37398906 | Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects |
| Q36691798 | Oxidation State Specific Generation of Arsines from Methylated Arsenicals Based on L- Cysteine Treatment in Buffered Media for Speciation Analysis by Hydride Generation - Automated Cryotrapping - Gas Chromatography-Atomic Absorption Spectrometry wit |
| Q34444053 | Pathway of human AS3MT arsenic methylation. |
| Q28468546 | Pentavalent arsenate transport by zebrafish phosphate transporter NaPi-IIb1 |
| Q39809704 | Persistence of DNA damage following exposure of human bladder cells to chronic monomethylarsonous acid |
| Q42939130 | Polymorphism of glutathione S-transferase (GST) variants and its effect on distribution of urinary arsenic species in people exposed to low inorganic arsenic in tap water: an exploratory study |
| Q24817001 | Profile of urinary arsenic metabolites during pregnancy |
| Q58124900 | Prospects for Exploiting Bacteria for Bioremediation of Metal Pollution |
| Q51785037 | Protein expression in the livers and urinary bladders of hamsters exposed to sodium arsenite. |
| Q42795789 | Realgar- and cinnabar-containing An-Gong-Niu-Huang Wan (AGNH) is much less acutely toxic than sodium arsenite and mercuric chloride |
| Q89550678 | Recognition of Trace Element Contamination Using Ficus macrophylla Leaves in Urban Environment |
| Q42806745 | Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1. |
| Q28385894 | Renal function is associated with indicators of arsenic methylation capacity in Bangladeshi adults |
| Q52620106 | Reorientation of the Methyl Group in MAs(III) is the Rate-Limiting Step in the ArsM As(III) S-Adenosylmethionine Methyltransferase Reaction. |
| Q37007987 | Respiratory cancer and inhaled inorganic arsenic in copper smelters workers: a linear relationship with cumulative exposure that increases with concentration |
| Q34086059 | Role of metabolic genes in blood arsenic concentrations of Jamaican children with and without autism spectrum disorder |
| Q64138001 | Serum folate and cobalamin levels and urinary dimethylarsinic acid in US children and adults |
| Q23923984 | Serum levels of the extracellular domain of the epidermal growth factor receptor in individuals exposed to arsenic in drinking water in Bangladesh |
| Q82184221 | Sister chromatid exchange analysis in smelting plant workers exposed to arsenic |
| Q37007978 | Speciation of arsenic in exfoliated urinary bladder epithelial cells from individuals exposed to arsenic in drinking water |
| Q90240126 | State of the science review of the health effects of inorganic arsenic: Perspectives for future research |
| Q27681235 | Structure of an As(III) S -Adenosylmethionine Methyltransferase: Insights into the Mechanism of Arsenic Biotransformation |
| Q46974689 | Sulforaphane, an activator of Nrf2, suppresses cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes |
| Q34701801 | The ATP-binding cassette transporter ABCB6 is induced by arsenic and protects against arsenic cytotoxicity |
| Q36339038 | The epigenetic effects of a high prenatal folate intake in male mouse fetuses exposed in utero to arsenic |
| Q47741603 | The respiratory health effects of geogenic (earth derived) PM10. |
| Q36929584 | The steroidogenic acute regulatory protein as a target of endocrine disruption in male reproduction |
| Q48764378 | Time course of arsenic species in the brain and liver of mice after oral administration of arsenate |
| Q28396711 | Transplacental arsenic carcinogenesis in mice |
| Q39185316 | Trivalent methylated arsenic metabolites induce apoptosis in human myeloid leukemic HL-60 cells through generation of reactive oxygen species |
| Q48501111 | Urinary Arsenic in Human Samples from Areas Characterized by Natural or Anthropogenic Pollution in Italy |
| Q28395532 | Urinary arsenic metabolites in children and adults exposed to arsenic in drinking water in Inner Mongolia, China |
| Q35110089 | Urinary arsenic metabolites of subjects exposed to elevated arsenic present in coal in Shaanxi Province, China |
| Q24811470 | Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. |
| Q42094906 | Volatilization of arsenic from polluted soil by Pseudomonas putida engineered for expression of the arsM Arsenic(III) S-adenosine methyltransferase gene |
| Q36579671 | shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells |
Search more.